Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Metadata
Title
Invited Commentary
Author
J Ken Champion
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 6/2005
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1381/0960892054222713

Other articles of this Issue 6/2005

Obesity Surgery 6/2005 Go to the issue

Report

Enterocutaneous Fistula: a Rare Complication of Laparoscopic Adjustable Gastric Banding

OriginalPaper

Bariatric Surgery: Asia-Pacific Perspective

OriginalPaper

Serum Hepatocyte Growth Factor Concentration in Obese Women Decreases after Vertical Banded Gastroplasty

Report

Symptomatic Pneumoperitoneum after Endoscopic Removal of Adjustable Gastric Band

OriginalPaper

Esophageal Dilatation after Laparoscopic Adjustable Gastric Banding: Definition and Strategy

OriginalPaper

Preoperative Resting Energy Expenditure Does Not Predict Weight Loss and Maintenance after Vertical Banded Gastroplasty